Yusuke Akamaru
Sakai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
When Tolerating Diet Is Not Enough: Hidden Underfeeding After Distal Gastrectomy.
Journal: The American surgeon
Published: July 28, 2026
NY-ESO-1 and PD-L1 as biomarkers associated with nivolumab response and outcome in unresectable or recurrent esophageal squamous cell carcinoma: a multicenter biomarker study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 21, 2026
A Resected Case of Leiomyosarcoma of the Transverse Mesocolon with Difficult Preoperative Diagnosis
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026
A Case of Pancreatic Acinar Cell Carcinoma Undergoing Two Hepatic Resections for Metachronous Liver Metastases
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026
Primary Malignant Melanoma of the Esophagus Treated with Nivolumab and Ipilimumab Post-Esophagectomy-A Case Report
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 24, 2025
Metabolic and functional pathways of gut microbiota in patients with gastric cancer.
Journal: Scientific reports
Published: October 19, 2025
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy for type 4 or large type 3 gastric cancer (OGSG 1402).
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: September 25, 2025
Circulating Tumor DNA Profiling Reveals Genomic Evolution in Recurrent Gastric or Gastroesophageal Junction Cancer.
Journal: Molecular diagnosis & therapy
Published: August 01, 2025
Clinical significance of comprehensive genomic profiling in unresectable or recurrent gastrointestinal stromal tumors: a multicenter retrospective cohort study.
Journal: Journal of gastroenterology
Published: August 01, 2025
Efficacy and safety of anamorelin for cancer cachexia in patients with unresectable or recurrent gastric cancer: a multicentre, open-label, randomised controlled trial.
Journal: EClinicalMedicine
Published: June 25, 2025
Preoperative stool scale is a risk factor for anastomotic leakage after minimally invasive low anterior resection for rectal cancer.
Journal: Surgery today
Published: June 06, 2025
A Case of Advanced Gastric Cancer with Cervical Lymph Node Metastasis Responding to SOX+Nivolumab and Treated with Conversion Surgery
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: May 13, 2025
Last Updated: 09/26/2026